PALISADE BIO INC (PALI) Stock Earnings & Estimates
USA - NASDAQ:PALI - US6963894026 - Common Stock
2 USD
-0.07 (-3.38%)
1.99 USD
-0.01 (-0.5%)
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | -100.00% | 250K | -100.00% | 55.101M | 94.141M 70.85% | 200.86M 113.36% | 112.39M -44.05% | 227.96M 102.83% | |||||
| EBITDA YoY % growth | -11.735M -10.88% | -15.308M -30.45% | -12.841M 16.12% | N/A -15.69% | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | |
| EBIT YoY % growth | -11.737M -9.94% | -15.311M -30.45% | -12.845M 16.11% | -15.642M -15.68% | -13.181M 11.29% | -23.059M -74.94% | -28.883M -25.25% | -29.874M -3.43% | -38.359M -28.40% | -4.917M 87.18% | 18.055M 467.16% | 48.793M 170.25% | |
| Operating Margin | N/A | N/A | -5,138.00% | N/A | N/A | N/A | N/A | -54.22% | -40.75% | -2.45% | 16.06% | 21.40% | |
| EPS YoY % growth | N/A | -247.95 91.73% | -29.10 88.26% | -11.90 59.53% | -1.76 85.09% | -1.26 28.15% | -1.17 7.06% | -1.15 2.32% | -1.07 6.53% | -0.15 86.03% | 1.38 1,020.25% | 3.71 169.63% |
All data in USD
| Q3 / 25 | Q4 / 25 | Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | |
|---|---|---|---|---|---|---|
| EPS Q2Q % growth | -0.38 83.48% | -0.37 75.98% | -0.45 4.08% | -0.45 21.57% | -0.46 -19.79% | -0.44 -19.12% |
| Revenue Q2Q % growth | ||||||
| EBITDA Q2Q % growth | N/A | N/A | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | -3.368M 6.27% | -4.466M -32.06% | -8.196M -122.27% | -9.594M -231.04% | -11.118M -230.14% | -11.995M -168.57% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q2 2025 Q2Q % growth | -0.58 82.53% | -0.57 | -0.01 | -1.42% |
| Q1 2025 Q2Q % growth | -0.47 89.76% | -0.71 | 0.24 | 34.17% |
| Q4 2024 Q2Q % growth | -1.55 76.02% | -2.03 | 0.48 | 23.66% |
| Q3 2024 Q2Q % growth | -2.32 64.85% | -3.42 | 1.10 | 32.15% |
| Q2 2024 Q2Q % growth | -3.32 58.24% | -2.99 | -0.33 | -11.13% |
| Q1 2024 Q2Q % growth | -4.59 43.33% | -4.90 | 0.31 | 6.25% |
| Q4 2023 Q2Q % growth | -6.45 -106.65% | -5.28 | -1.17 | -22.19% |
| Q3 2023 Q2Q % growth | -6.60 89.00% | -6.03 | -0.57 | -9.49% |
| Q2 2023 Q2Q % growth | -7.95 91.17% | -6.93 | -1.02 | -14.70% |
| Q1 2023 Q2Q % growth | -8.10 95.85% | -11.06 | 2.96 | 26.78% |
| Q4 2022 Q2Q % growth | 97.05 61.75% | -37.26 | 134.31 | 360.50% |
| Q3 2022 Q2Q % growth | -60.00 -119.05% | -61.20 | 1.20 | 1.96% |
| Q2 2022 Q2Q % growth | -90.00 -11,900.00% | -175.95 | 85.95 | 48.85% |
| Q1 2022 Q2Q % growth | -195.00 | -214.20 | 19.20 | 8.96% |
| Q4 2021 Q2Q % growth | 60.00 | -179.78 | 239.78 | 133.38% |
| Q3 2021 Q2Q % growth | 315.00 | -275.40 | 590.40 | 214.38% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q1 2024 Q2Q % growth | -100.00% | % | ||
| Q4 2021 Q2Q % growth | -100.00% | % | ||
| Q3 2021 Q2Q % growth | -100.00% | % | ||
| Q2 2021 Q2Q % growth | -100.00% | % | ||
| Q1 2021 Q2Q % growth | -100.00% | % | ||
| Q4 2020 Q2Q % growth | 2.5K | % | ||
| Q3 2020 Q2Q % growth | 2.5K | % | ||
| Q2 2020 Q2Q % growth | 2.5K -68.35% | % | ||
| Q1 2020 Q2Q % growth | 6K 140.00% | % |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 0% | 0% | 0% | -18.21% |
| Revenue | N/A | N/A | N/A | N/A |